EKOP Fundamental Analysis - EKOPAK NV

Fundamental Rating

EKOP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 42 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of EKOP have multiple concerns. EKOP is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EKOP has reported negative net income.

EKOP had a negative operating cash flow in the past year.

EKOP had negative earnings in each of the past 5 years.

In the past 5 years EKOP reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -10.96%, EKOP is doing worse than 71.43% of the companies in the same industry.

EKOP's Return On Equity of -35.86% is on the low side compared to the rest of the industry. EKOP is outperformed by 71.43% of its industry peers.

		Industry Rank	Sector Rank
ROA	-10.96%
ROE	-35.86%
ROIC	N/A

ROA(3y)-4.22%

ROA(5y)-2.9%

ROE(3y)-12.98%

ROE(5y)-8.4%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of EKOP (28.12%) is worse than 76.19% of its industry peers.

EKOP's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for EKOP so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	28.12%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y4.64%

GM growth 5Y-5.79%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EKOP does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, EKOP has about the same amount of shares outstanding.

The number of shares outstanding for EKOP has been increased compared to 5 years ago.

The debt/assets ratio for EKOP is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.08, we must say that EKOP is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of -0.08, EKOP is not doing good in the industry: 76.19% of the companies in the same industry are doing better.

A Debt/Equity ratio of 1.12 is on the high side and indicates that EKOP has dependencies on debt financing.

EKOP's Debt to Equity ratio of 1.12 is in line compared to the rest of the industry. EKOP outperforms 40.48% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.12
Debt/FCF	N/A
Altman-Z	-0.08

ROIC/WACCN/A

WACC5.76%

2.3 Liquidity

A Current Ratio of 0.82 indicates that EKOP may have some problems paying its short term obligations.

With a Current ratio value of 0.82, EKOP is not doing good in the industry: 71.43% of the companies in the same industry are doing better.

EKOP has a Quick Ratio of 0.82. This is a bad value and indicates that EKOP is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.65, EKOP is not doing good in the industry: 73.81% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.82
Quick Ratio	0.65

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EKOP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -239.72%.

The Revenue for EKOP has decreased by -32.41% in the past year. This is quite bad

The Revenue has been growing by 36.09% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-239.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-215.69%

Revenue 1Y (TTM)-32.41%

Revenue growth 3Y61.78%

Revenue growth 5Y36.09%

Sales Q2Q%-33.44%

3.2 Future

EKOP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.98% yearly.

The Revenue is expected to grow by 25.77% on average over the next years. This is a very strong growth

EPS Next Y-81.63%

EPS Next 2Y14.29%

EPS Next 3Y24.69%

EPS Next 5Y60.98%

Revenue Next Year11.74%

Revenue Next 2Y19.97%

Revenue Next 3Y14.97%

Revenue Next 5Y25.77%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

EKOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year EKOP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as EKOP's earnings are expected to grow with 24.69% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y14.29%

EPS Next 3Y24.69%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

EKOP does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EKOPAK NV

EBR:EKOP (12/3/2025, 3:49:23 PM)

4.04

-0.04 (-0.98%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)11-04 2025-11-04/amc

Earnings (Next)N/A N/A

Inst Owners0.73%

Inst Owner ChangeN/A

Ins Owners82.57%

Ins Owner ChangeN/A

Market Cap70.70M

Revenue(TTM)36.74M

Net Income(TTM)-17.55M

Analysts43.64

Price Target4.44 (9.9%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-18.69%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-134.21%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-10.71%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.92
P/FCF	N/A
P/OCF	N/A
P/B	1.44
P/tB	660.75
EV/EBITDA	N/A

EPS(TTM)-1.09

EYN/A

EPS(NY)-0.17

Fwd EYN/A

FCF(TTM)-1.52

FCFYN/A

OCF(TTM)-0.63

OCFYN/A

SpS2.1

BVpS2.8

TBVpS0.01

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-10.96%
ROE	-35.86%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	28.12%
FCFM	N/A

ROA(3y)-4.22%

ROA(5y)-2.9%

ROE(3y)-12.98%

ROE(5y)-8.4%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y4.64%

GM growth 5Y-5.79%

F-Score1

Asset Turnover0.23

Health

		Industry Rank	Sector Rank
Debt/Equity	1.12
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	176.27%
Cap/Sales	42.53%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.82
Quick Ratio	0.65
Altman-Z	-0.08

F-Score1

WACC5.76%

ROIC/WACCN/A

Cap/Depr(3y)366.86%

Cap/Depr(5y)479.35%

Cap/Sales(3y)50.41%

Cap/Sales(5y)51.41%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-239.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-215.69%

EPS Next Y-81.63%

EPS Next 2Y14.29%

EPS Next 3Y24.69%

EPS Next 5Y60.98%

Revenue 1Y (TTM)-32.41%

Revenue growth 3Y61.78%

Revenue growth 5Y36.09%

Sales Q2Q%-33.44%

Revenue Next Year11.74%

Revenue Next 2Y19.97%

Revenue Next 3Y14.97%

Revenue Next 5Y25.77%

EBIT growth 1Y-306.84%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year418.18%

EBIT Next 3Y159.4%

EBIT Next 5Y139.97%

FCF growth 1Y-76.88%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-92.53%

OCF growth 3YN/A

OCF growth 5YN/A

EKOPAK NV / EKOP.BR FAQ

What is the ChartMill fundamental rating of EKOPAK NV (EKOP.BR) stock?

ChartMill assigns a fundamental rating of 1 / 10 to EKOP.BR.

What is the valuation status for EKOP stock?

ChartMill assigns a valuation rating of 1 / 10 to EKOPAK NV (EKOP.BR). This can be considered as Overvalued.

How profitable is EKOPAK NV (EKOP.BR) stock?

EKOPAK NV (EKOP.BR) has a profitability rating of 0 / 10.

Can you provide the expected EPS growth for EKOP stock?

The Earnings per Share (EPS) of EKOPAK NV (EKOP.BR) is expected to decline by -81.63% in the next year.

How sustainable is the dividend of EKOPAK NV (EKOP.BR) stock?

The dividend rating of EKOPAK NV (EKOP.BR) is 0 / 10 and the dividend payout ratio is 0%.

EKOPAK NV (EKOP.BR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

EKOPAK NV / EKOP.BR FAQ

What is the ChartMill fundamental rating of EKOPAK NV (EKOP.BR) stock?

What is the valuation status for EKOP stock?

How profitable is EKOPAK NV (EKOP.BR) stock?

Can you provide the expected EPS growth for EKOP stock?

How sustainable is the dividend of EKOPAK NV (EKOP.BR) stock?